<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>7(1)</volume><submitter>Duchi S</submitter><pubmed_abstract>Three-dimensional (3D) bioprinting is driving major innovations in the area of cartilage tissue engineering. Extrusion-based 3D bioprinting necessitates a phase change from a liquid bioink to a semi-solid crosslinked network achieved by a photo-initiated free radical polymerization reaction that is known to be cytotoxic. Therefore, the choice of the photocuring conditions has to be carefully addressed to generate a structure stiff enough to withstand the forces phisiologically applied on articular cartilage, while ensuring adequate cell survival for functional chondral repair. We recently developed a handheld 3D printer called "Biopen". To progress towards translating this freeform biofabrication tool into clinical practice, we aimed to define the ideal bioprinting conditions that would deliver a scaffold with high cell viability and structural stiffness relevant for chondral repair. To fulfill those criteria, free radical cytotoxicity was confined by a co-axial Core/Shell separation. This system allowed the generation of Core/Shell GelMa/HAMa bioscaffolds with stiffness of 200KPa, achieved after only 10 seconds of exposure to 700 mW/cm&lt;sup>2&lt;/sup> of 365 nm UV-A, containing >90% viable stem cells that retained proliferative capacity. Overall, the Core/Shell handheld 3D bioprinting strategy enabled rapid generation of high modulus bioscaffolds with high cell viability, with potential for in situ surgical cartilage engineering.</pubmed_abstract><journal>Scientific reports</journal><pagination>5837</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5517463</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Handheld Co-Axial Bioprinting: Application to in situ surgical cartilage repair.</pubmed_title><pmcid>PMC5517463</pmcid><pubmed_authors>Duchi S</pubmed_authors><pubmed_authors>Di Bella C</pubmed_authors><pubmed_authors>Quigley AF</pubmed_authors><pubmed_authors>Pivonka P</pubmed_authors><pubmed_authors>Wallace G</pubmed_authors><pubmed_authors>Blanchard R</pubmed_authors><pubmed_authors>Onofrillo C</pubmed_authors><pubmed_authors>O'Connell CD</pubmed_authors><pubmed_authors>Choong PFM</pubmed_authors><pubmed_authors>Kapsa RMI</pubmed_authors><pubmed_authors>Augustine C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Handheld Co-Axial Bioprinting: Application to in situ surgical cartilage repair.</name><description>Three-dimensional (3D) bioprinting is driving major innovations in the area of cartilage tissue engineering. Extrusion-based 3D bioprinting necessitates a phase change from a liquid bioink to a semi-solid crosslinked network achieved by a photo-initiated free radical polymerization reaction that is known to be cytotoxic. Therefore, the choice of the photocuring conditions has to be carefully addressed to generate a structure stiff enough to withstand the forces phisiologically applied on articular cartilage, while ensuring adequate cell survival for functional chondral repair. We recently developed a handheld 3D printer called "Biopen". To progress towards translating this freeform biofabrication tool into clinical practice, we aimed to define the ideal bioprinting conditions that would deliver a scaffold with high cell viability and structural stiffness relevant for chondral repair. To fulfill those criteria, free radical cytotoxicity was confined by a co-axial Core/Shell separation. This system allowed the generation of Core/Shell GelMa/HAMa bioscaffolds with stiffness of 200KPa, achieved after only 10 seconds of exposure to 700 mW/cm&lt;sup>2&lt;/sup> of 365 nm UV-A, containing >90% viable stem cells that retained proliferative capacity. Overall, the Core/Shell handheld 3D bioprinting strategy enabled rapid generation of high modulus bioscaffolds with high cell viability, with potential for in situ surgical cartilage engineering.</description><dates><release>2017-01-01T00:00:00Z</release><publication>2017 Jul</publication><modification>2024-11-06T01:52:29.309Z</modification><creation>2019-03-27T02:50:57Z</creation></dates><accession>S-EPMC5517463</accession><cross_references><pubmed>28724980</pubmed><doi>10.1038/s41598-017-05699-x</doi></cross_references></HashMap>